• Novobiocin Links DNA Replication to Protoplast Growth

  2026-09-20

  The reference study shows that DNA replication is functionally coupled to plasma membrane expansion and vacuole formation in Enterococcus faecalis protoplasts. By varying novobiocin timing and using quantitative PCR, the authors distinguish replication-dependent effects on cell enlargement from direct DNA degradation and establish a time-resolved framework for studying bacterial morphogenesis.

• Nystatin (Fungicidin): Mechanism and Research Use

  2026-09-19

  Nystatin, also called Fungicidin, is a polyene antifungal that targets ergosterol-rich fungal membranes. Product data support research use against Candida species, adhesion phenotypes, and liposomal Aspergillus models, while clinical and ocular applications require separate evidence.

• Apigenin: An Evidence-Weighted Assay Strategy

  2026-09-18

  Apigenin connects HDAC-linked tumor suppression with network-guided neuroprotection. This evidence-weighted guide shows how to select orthogonal assays, interpret context-dependent biology, and use N1828 effectively in oncology and neuroinflammation research.

• Radiotherapy, PD-1/TIGIT Blockade, and Immune Memory

  2026-09-18

  A 2025 Cancer Letters study shows that radiotherapy combined with PD-1 and TIGIT blockade can produce systemic tumor control and durable immune memory in multiple mouse models. The work identifies CD8+ T cells and activated M1 macrophage–T-cell crosstalk as central mechanisms linking local irradiation to abscopal responses.

• PD 173074: From FGFR1 Mechanism to LUAD Translation

  2026-09-17

  PD 173074 is more than a selective FGFR1 research probe: its dual FGFR1 and VEGFR2 activity creates a practical framework for connecting pathway biology, angiogenesis, and biomarker-defined lung adenocarcinoma research. This article examines how CENPO-associated risk biology can guide experimental validation while keeping drug-sensitivity correlations distinct from therapeutic proof.

• Carvedilol Phosphate: From GPCR Signals to Liver IRI

  2026-09-17

  A translational framework for using Carvedilol Phosphate to interrogate adrenergic GPCR signaling, Arrb2 biology, macrophage polarization, and 6-ketoLCA-associated protection in hepatic ischemia–reperfusion research.

• HyperTrap Heparin HP Column for Stemness Research

  2026-09-16

  The HyperTrap Heparin HP Column combines a preloaded format with fine-particle HyperChrom Heparin HP Agarose for reproducible protein capture, cleanup, and fractionation. Its practical value in CCR7–Notch1 research is indirect but important: it helps prepare or refine signaling proteins before cellular assays, while offering a controllable workflow for coagulation, growth-factor, and nucleic-acid-enzyme applications.

• Dual-Action Inhibitors Promote p38α Dephosphorylation

  2026-09-16

  The reference preprint shows that selected kinase inhibitors can both suppress p38α MAP kinase activity and accelerate WIP1-mediated dephosphorylation of its activation-loop phosphothreonine. Structural data suggest that inhibitor-stabilized activation-loop conformations expose the phosphosite, offering a design principle for kinase inhibitors that control both catalytic activity and phosphatase access.

• Octenidine: From Membrane Disruption to Translation

  2026-09-15

  A mechanistic and strategic guide to using Octenidine dihydrochloride in antimicrobial research, assay design, and next-generation antiseptic development.

• Tamoxifen Workflows for Inducible Inflammation Models

  2026-09-15

  Tamoxifen combines selective estrogen receptor modulation with temporal control of CreER-mediated gene knockout, making it useful for separating disease initiation from recurrence. This workflow translates the GZMK airway-inflammation findings into practical genetic, phenotypic, and troubleshooting strategies while preserving essential pharmacological controls.

• CD44 Metabolic Rewiring in IDH-Mutant Leukemia

  2026-09-14

  The reference study identifies CD44-mediated metabolic rewiring as a functional dependency of IDH-mutant leukemia, linking pentose phosphate pathway activity and NADPH production to sustained R-2HG synthesis. Its findings suggest that combining mutant IDH inhibition with CD44 blockade may address a metabolic vulnerability that is not fully captured by 2-HG suppression alone.

• FLOT1–FOSL2–EphA2 Signaling in Alzheimer’s Disease

  2026-09-14

  A 2026 Neuropharmacology study identifies a FLOT1–FOSL2–EphA2 regulatory axis that activates p38/MAPK signaling and promotes pro-inflammatory microglial polarization in an APP/PS1 model. FLOT1 silencing reduced neuroinflammatory responses and improved spatial memory, providing a mechanistic framework for connecting lipid-raft-associated regulation with cognitive decline in Alzheimer’s disease.

• Maternal IL-17A and Neonatal GBS Risk

  2026-09-13

  A prospective Moroccan mother–newborn study identifies reduced maternal IL-17A responses as a candidate marker of invasive Group B Streptococcus disease after vertical transmission. By combining maternal and cord-blood cytokine profiling with ex vivo TLR stimulation, the work connects immune-response phenotyping with neonatal risk stratification while highlighting important limits for clinical translation.

• MLKL Polymerization and Lysosomal Membrane Permeabilization

  2026-09-12

  The reference study identifies MLKL polymerization-induced lysosomal membrane permeabilization as a critical execution step in necroptosis, placing lysosomal cathepsin B release between necrosome activation and plasma membrane rupture. Its live-cell imaging, MLKL-domain perturbation, and cathepsin B loss-of-function experiments provide a framework for dissecting lysosomal enzyme inhibition in regulated cell death.

• Baricitinib (LY3009104): JAK1/2–STAT3

  2026-09-11

  Baricitinib, also known as LY3009104 and INCB028050, is an orally bioavailable, ATP-competitive JAK1/JAK2 inhibitor. Its low-nanomolar biochemical potency and suppression of STAT3 phosphorylation support research on IL-6, IL-23, immune signaling, and preclinical arthritis models.

8135 records 1/543 page Next 12345 下5页 Last page